Posen signs with Selective Beauty
This article was originally published in The Rose Sheet
Executive Summary
Fashion designer Zac Posen has inked his first fragrance deal with Selective Beauty, the firm announces July 26. Selective Beauty will handle the development, marketing, distribution and public relations for the brand, with the first scent expected to launch in spring 2009. The French fragrance firm recently opened a subsidiary in the United States,; this is one of the first licensing agreements Selective Beauty U.S. has entered into with an American brand after establishing its distribution network in the country. "This is a tremendous partnership," says Sylvie Ganter, president of Selective Beauty U.S. Posen "is our dream partner, the true epitome of modern luxury"...
You may also be interested in...
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.